加拿大的囊性纤维化病的社会经济负担
Olivier D Laflamme1, Noah Johnson1, Kim Steele2
1Department of Community Health, and Epidemiology, Dalhousie University, Halifax, Nova Scotia, Canada.
BMJ open respiratory research
|August 9, 2024
概括
2021年,加拿大的囊性纤维化 (CF) 的社会经济负担总额为4.14亿加元. 本研究量化了与CF相关的重大成本,包括直接的医疗费用和因生产力丧失而造成的间接成本.
科学领域:
- 卫生经济学 卫生经济学
- 公共卫生 公共卫生
- 流行病学 流行病学
背景情况:
- 疾病成本 (COI) 研究对于了解疾病负担至关重要.
- 缺乏报告囊性纤维化 (CF) 成本的标准化方法,阻碍了准确的社会经济影响评估.
- 这项研究全面报告了CF在加拿大的社会经济负担.
研究的目的:
- 量化加拿大的囊性纤维化病的社会经济负担.
- 建立CF疾病研究未来成本的基准.
- 提供以社区为导向的观点,以了解与CF生活的经济影响.
主要方法:
- 采用了以流行为基础的自下而上的人力资本方法.
- 数据来自加拿大CF注册,疾病负担调查和公共来源.
- 从医疗保健系统,个人/护理人员,变量 (药物) 和社会视角分析了成本,包括直接,间接和无形领域.
主要成果:
- 2021年加拿大的CF总社会经济负担估计为4.14亿加元.
- 直接成本占总成本的三分之二,药品占直接支出的一半.
- 间接成本,主要是缺勤,占总社会经济负担的三分之一.
结论:
- 本研究提供了加拿大CF疾病分析的综合社会经济成本.
- 它强调了CF对个人,护理人员,医疗保健系统和社会的重大经济影响.
- 这些发现是未来研究和政策制定的关键基准.
相关概念视频
01:24Cystic Fibrosis: Management
150
Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...
Sinus disease and chronic...
150
01:23Cystic Fibrosis: Pathogenesis
201
Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
201
01:20COPD: Pathogenesis and Clinical Features
248
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
248
01:27Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
2.5K
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
Medical History
2.5K
01:20Chronic Obstructive Pulmonary Disease-I: Introduction
2.8K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
2.8K
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
2.7K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
2.7K